TherapeuticsMD, Inc 10-K for FY2022
TherapeuticsMD, Inc. (TXMD)
10-K
2023-04-07
For: 2022-12-31
View Original
Added on
April 11, 2026
About this 10-K
TherapeuticsMD, Inc filed this 10-K on April 7, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $69.96M
- up 2619.1% from $2.57M a year earlier
- Net income
- $112M
- compared with a net loss of $172.42M a year earlier
- Diluted EPS
- $11.96
- compared with -$21.66 a year earlier